04.21.14
French company Implanet, a medical technology firm specializing in vertebral and knee surgery implants has appointed Brian T. Ennis as a new member of its board of directors.
Ennis brings more than 30 years of experience in the development and growth of medical technology companies. After 11 years at Stryker Corp., where he held various marketing and vice president/general management positions in both Europe and the United States, he was president, international at Wright Medical Group, which specialized in orthopedic devices and biotechnologies; president at Empi, a company that develops electrotherapeutic medical solutions; and president and CEO at Etex Corporation for a little more than six years.
“I am delighted to be joining Implanet’s board of directors,” Ennis said. “I have had the pleasure of following Implanet since its inception in 2007 and throughout its subsequent development. The executive management team has admirably built a solid foundation for growth, skillfully implemented a market penetration strategy for the United States, deftly maneuvered through the regulatory clearance process and aptly demonstrated the innovative Jazz technology platform’s clinical merits. I look forward to assisting the management team in securing respected key opinion leaders in the spine market segment, rapidly expanding the U.S. distribution channel, and promoting both the economic value and clinical benefits of this innovative technology.”
“We are delighted with Brian T. Ennis’ arrival as a director,” said CEO Ludovic Lastennet. “He has substantial and highly-successful experience in the development of divisions or companies in our sector of activity. He will be an additional asset to accompany Implanet’s international growth.”
Ennis brings more than 30 years of experience in the development and growth of medical technology companies. After 11 years at Stryker Corp., where he held various marketing and vice president/general management positions in both Europe and the United States, he was president, international at Wright Medical Group, which specialized in orthopedic devices and biotechnologies; president at Empi, a company that develops electrotherapeutic medical solutions; and president and CEO at Etex Corporation for a little more than six years.
“I am delighted to be joining Implanet’s board of directors,” Ennis said. “I have had the pleasure of following Implanet since its inception in 2007 and throughout its subsequent development. The executive management team has admirably built a solid foundation for growth, skillfully implemented a market penetration strategy for the United States, deftly maneuvered through the regulatory clearance process and aptly demonstrated the innovative Jazz technology platform’s clinical merits. I look forward to assisting the management team in securing respected key opinion leaders in the spine market segment, rapidly expanding the U.S. distribution channel, and promoting both the economic value and clinical benefits of this innovative technology.”
“We are delighted with Brian T. Ennis’ arrival as a director,” said CEO Ludovic Lastennet. “He has substantial and highly-successful experience in the development of divisions or companies in our sector of activity. He will be an additional asset to accompany Implanet’s international growth.”